Journal Logo

Articles by Carol C. Cheung, MD, PhD, JD

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)

Cheung, Carol C.; Barnes, Penny; Bigras, Gilbert; More

Applied Immunohistochemistry & Molecular Morphology. 27(10):699-714, November/December 2019.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry

Cheung, Carol C.; D’Arrigo, Corrado; Dietel, Manfred; More

Applied Immunohistochemistry & Molecular Morphology. 25(4):227-230, April 2017.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories

Torlakovic, Emina E.; Cheung, Carol C.; D’Arrigo, Corrado; More

Applied Immunohistochemistry & Molecular Morphology. 25(3):151-159, March 2017.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine – Part 2: Immunohistochemistry Test Performance Characteristics

Torlakovic, Emina E.; Cheung, Carol C.; D’Arrigo, Corrado; More

Applied Immunohistochemistry & Molecular Morphology. 25(2):79-85, February 2017.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers

Cheung, Carol C.; D’Arrigo, Corrado; Dietel, Manfred; More

Applied Immunohistochemistry & Molecular Morphology. 25(1):4-11, January 2017.